Unbalanced recovery of regulatory and effector T cells after allogeneic stem cell transplantation contributes to chronic GVHD
Open Access
- 4 February 2016
- journal article
- research article
- Published by American Society of Hematology in Blood
- Vol. 127 (5) , 646-657
Abstract
Key Points: Homeostatic recovery after allogeneic HSCT favors the production, expansion, and survival of effector T cells over CD4Tregs. Unbalanced reconstitution of regulatory and effector T-cell subsets contributes to the development of chronic graft-versus-host disease.Keywords
This publication has 46 references indexed in Scilit:
- Multiparameter single-cell profiling of human CD4+FOXP3+ regulatory T-cell populations in homeostatic conditions and during graft-versus-host diseaseBlood, 2013
- Advances in graft-versus-host disease biology and therapyNature Reviews Immunology, 2012
- Low telomerase activity in CD4+ regulatory T cells in patients with severe chronic GVHD after hematopoietic stem cell transplantationBlood, 2011
- Thymic T-cell development in allogeneic stem cell transplantationBlood, 2011
- Infusion of ex vivo expanded T regulatory cells in adults transplanted with umbilical cord blood: safety profile and detection kineticsBlood, 2011
- Altered regulatory T cell homeostasis in patients with CD4+ lymphopenia following allogeneic hematopoietic stem cell transplantationJournal of Clinical Investigation, 2010
- Human T Regulatory Cell Therapy: Take a Billion or So and Call Me in the MorningImmunity, 2009
- Escape from suppression: tumor-specific effector cells outcompete regulatory T cells following stem-cell transplantationBlood, 2008
- The impact of regulatory T cells on T-cell immunity following hematopoietic cell transplantationBlood, 2008
- Two subsets of memory T lymphocytes with distinct homing potentials and effector functionsNature, 1999